Cellular and Molecular Mechanisms of the Tumor Stroma in Colorectal Cancer: Insights into Disease Progression and Therapeutic Targets
- PMID: 37760801
- PMCID: PMC10525158
- DOI: 10.3390/biomedicines11092361
Cellular and Molecular Mechanisms of the Tumor Stroma in Colorectal Cancer: Insights into Disease Progression and Therapeutic Targets
Abstract
Colorectal cancer (CRC) is a major health burden worldwide and is the third most common type of cancer. The early detection and diagnosis of CRC is critical to improve patient outcomes. This review explores the intricate interplay between the tumor microenvironment, stromal interactions, and the progression and metastasis of colorectal cancer. The review begins by assessing the gut microbiome's influence on CRC development, emphasizing its association with gut-associated lymphoid tissue (GALT). The role of the Wnt signaling pathway in CRC tumor stroma is scrutinized, elucidating its impact on disease progression. Tumor budding, its effect on tumor stroma, and the implications for patient prognosis are investigated. The review also identifies conserved oncogenic signatures (COS) within CRC stroma and explores their potential as therapeutic targets. Lastly, the seed and soil hypothesis is employed to contextualize metastasis, accentuating the significance of both tumor cells and the surrounding stroma in metastatic propensity. This review highlights the intricate interdependence between CRC cells and their microenvironment, providing valuable insights into prospective therapeutic approaches targeting tumor-stroma interactions.
Keywords: Wnt signaling pathway; colorectal cancer; conserved oncogenic signatures; gut microbiome; gut-associated lymphoid tissue; metastasis; tumor budding; tumor stroma.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Exploring the gut microbiome's role in colorectal cancer: diagnostic and prognostic implications.Front Immunol. 2024 Oct 17;15:1431747. doi: 10.3389/fimmu.2024.1431747. eCollection 2024. Front Immunol. 2024. PMID: 39483461 Free PMC article. Review.
-
Exosomes in tumor-stroma crosstalk: Shaping the immune microenvironment in colorectal cancer.FASEB J. 2024 Mar 31;38(6):e23548. doi: 10.1096/fj.202302297R. FASEB J. 2024. PMID: 38491832 Review.
-
Neural influences in colorectal cancer progression and therapeutic strategies.Int J Colorectal Dis. 2025 May 16;40(1):120. doi: 10.1007/s00384-025-04887-w. Int J Colorectal Dis. 2025. PMID: 40379990 Free PMC article. Review.
-
The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy.Transl Oncol. 2025 Mar;53:102307. doi: 10.1016/j.tranon.2025.102307. Epub 2025 Feb 3. Transl Oncol. 2025. PMID: 39904281 Free PMC article. Review.
-
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10. J Urol. 2005. PMID: 15592017 Review.
Cited by
-
Fibroblasts activated by miRs-185-5p, miR-652-5p, and miR-1246 shape the tumor microenvironment in triple-negative breast cancer via PATZ1 downregulation.Cell Mol Life Sci. 2025 Jul 25;82(1):287. doi: 10.1007/s00018-025-05781-y. Cell Mol Life Sci. 2025. PMID: 40711489 Free PMC article.
-
CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challenges.Nat Rev Gastroenterol Hepatol. 2025 Jul;22(7):463-480. doi: 10.1038/s41575-025-01062-y. Epub 2025 Apr 14. Nat Rev Gastroenterol Hepatol. 2025. PMID: 40229574 Review.
-
Adoptive immune cell therapy for colorectal cancer.Front Immunol. 2025 Apr 1;16:1557906. doi: 10.3389/fimmu.2025.1557906. eCollection 2025. Front Immunol. 2025. PMID: 40236691 Free PMC article. Review.
-
Contrast-enhanced CT-derived extracellular volume fraction in preoperative prediction of tumor-stroma ratio in colorectal cancer.Abdom Radiol (NY). 2025 Jul 23. doi: 10.1007/s00261-025-05136-y. Online ahead of print. Abdom Radiol (NY). 2025. PMID: 40699289
References
-
- Araghi M., Arnold M., Rutherford M.J., Guren M.G., Cabasag C.J., Bardot A., Ferlay J., Tervonen H., Shack L., Woods R.R., et al. Colon and rectal cancer survival in seven high-income countries 2010-2014: Variation by age and stage at diagnosis (the ICBP SURVMARK-2 project) Gut. 2021;70:114–126. doi: 10.1136/gutjnl-2020-320625. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources